Priveterra Acquisition Corp.
We intend to focus on the medical technology sector. Our management team and board (collectively referred to as the “team”) possess a synergistic combination of executive, strategic, operational, financial and transactional experience in this sector, and have demonstrated a strong track record of identifying and creating significant stockholder value at leading medical technology companies.
(Note: Priveterra Acquisition Corp. priced its upsized IPO on Feb. 8, 2021, of 24 million units, up from 20 million, at $10 each to raise $240 million.)
|Address||300 SE 2nd Street, Suite 600 Fort Lauderdale, Florida 33301|
|View Prospectus:||Priveterra Acquisition Corp.|
|Revenues||$0 mil (last 12 months)|
|Net Income||$0 mil (last 12 months)|
|Price range||$10.00 - $10.00|
|Est. $ Volume||$240.0 mil|
|Manager / Joint Managers||Wells Fargo Securities/Guggenheim Securities|
|CO-Managers||Odeon Capital Group|
|Expected To Trade:||2/9/2021|
|Quiet Period Expiration Date:||Available only to Subscribers|
|Lock-Up Period Expiration Date:||Available only to Subscribers|
|SCOOP Rating||Available only to Subscribers|
|Rating Change||Available only to Subscribers|